These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29744601)

  • 1. Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.
    Iwamura H; Hatakeyama S; Sato M; Ohyama C
    Med Oncol; 2018 May; 35(6):94. PubMed ID: 29744601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder recurrence after radical nephroureterectomy: predictors and impact on oncological outcomes.
    Elalouf V; Xylinas E; Klap J; Pignot G; Delongchamps NB; Saighi D; Peyromaure M; Flam T; Zerbib M
    Int J Urol; 2013 Nov; 20(11):1078-83. PubMed ID: 23521657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
    Sanderson KM; Rouprêt M
    BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
    Momota M; Hatakeyama S; Yamamoto H; Iwamura H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Iwabuchi I; Ogasawara M; Kawaguchi T; Ohyama C
    Oncotarget; 2018 May; 9(33):23047-23057. PubMed ID: 29796171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-based molecular markers in upper tract urothelial carcinoma and their prognostic implications.
    Favaretto RL; Zequi SC; Oliveira RAR; Santana T; Costa WH; Cunha IW; Guimarães GC
    Int Braz J Urol; 2018; 44(1):22-37. PubMed ID: 29135410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Ishioka J; Saito K; Kijima T; Nakanishi Y; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Sakura M; Yonese J; Morimoto S; Noro A; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K
    BJU Int; 2015 May; 115(5):705-12. PubMed ID: 24612074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival.
    Boorjian SA; Tollefson MK; Cheville JC; Costello BA; Thapa P; Frank I
    J Urol; 2011 Nov; 186(5):1796-802. PubMed ID: 21944088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
    Kusaka A; Hatakeyama S; Hosogoe S; Hamano I; Iwamura H; Fujita N; Fukushi K; Narita T; Hagiwara K; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Ohyama C
    Oncotarget; 2017 Sep; 8(39):65492-65505. PubMed ID: 29029448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
    Kusaka A; Hatakeyama S; Hosogoe S; Hamano I; Iwamura H; Fujita N; Fukushi K; Narita T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Ohyama C
    Med Oncol; 2017 May; 34(5):90. PubMed ID: 28397105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for bladder recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Cho DS; Kim SI; Ahn HS; Kim SJ
    Urol Int; 2013; 91(2):153-9. PubMed ID: 23391941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma.
    Milojevic B; Dzamic Z; Kajmakovic B; Durutovic O; Bumbasirevic U; Sipetic Grujicic S
    Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is frozen section analysis of ureteral margins at time of radical cystectomy useful?
    Satkunasivam R; Hu B; Daneshmand S
    Curr Urol Rep; 2015 Jun; 16(6):38. PubMed ID: 25940187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association.
    Hara T; Fujimoto H; Sakura M; Inokuchi J; Nishiyama H; Miyazaki J; Ohyama C; Koie T; Kikuchi E; Hinotsu S;
    Int J Urol; 2015 Nov; 22(11):1013-20. PubMed ID: 26242807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer.
    Osterman CK; Alanzi J; Lewis JD; Kaufman EL; Narayan V; Boursi B; Vajravelu RK; Scott FI; Malkowicz SB; Mamtani R
    Clin Genitourin Cancer; 2018 Jun; 16(3):235-239. PubMed ID: 29287969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.